Evidence map›Paper›PMID 24277933›Full record

ArticleMolecular and cellular biology2014

Psy2 targets the PP4 family phosphatase Pph3 to dephosphorylate Mth1 and repress glucose transporter gene expression.

Hui Ma, Bong-Kwan Han, Marisela Guaderrama, Aaron Aslanian, John R Yates, Tony Hunter, Curt Wittenberg

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hui MaMolecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California, USA.
Bong-Kwan Han
Marisela Guaderrama
Aaron Aslanian
John R Yates
Tony Hunter
Curt Wittenberg
Scripps Research Institute · USSalk Institute for Biological Studies · US

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Ye Zheng · 1985 to 2026
$82.8M
ZDS2P REGULATES SWE1P-DEPENDENT POLARIZED CELL GROWTH IN S CEREVISIAEP41RR011823 · NCRR · UNIVERSITY OF WASHINGTON · PI DAVIS, TRACY · 1996 to 2011
$24.7M
SOMATIC CELL CYCLE REGULATION BY PHOSPHORYLATIONR01CA080100 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI HUNTER, TONY R. · 1999 to 2018
$13.1M
SIGNAL TRANSDUCTION BY TYROSINE PHOSPHORYLATIONR01CA082683 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI HUNTER, TONY R. · 1999 to 2019
$12.2M
REGULATION OF G1-SPECIFIC GENE EXPRESSION IN YEASTR01GM059441 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI WITTENBERG, CURT · 2000 to 2016
$6.9M
ROLE OF CYCLINS IN CONTROL OF THE YEAST CELL CYCLER01GM043487 · NIGMS · SCRIPPS RESEARCH INSTITUTE · PI WITTENBERG, CURT · 1990 to 2005
$2.0M
Regulation of Glucose Signaling in Eukaryotic CellsF32DK060367 · NIDDK · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI MA, HUI · 2001 to 2003
$136k
NCI NIH HHS CA14195NCI NIH HHS CA80100NCI NIH HHS CA82683NCI NIH HHS P30 CA014195NCI NIH HHS R01 CA080100NCI NIH HHS R01 CA082683NCRR NIH HHS P41 RR011823NIDDK NIH HHS DK60367-02NIDDK NIH HHS F32 DK060367NIGMS NIH HHS GM043487NIGMS NIH HHS GM059441NIGMS NIH HHS R01 GM043487NIGMS NIH HHS R01 GM059441
6 · The paper itself

Abstract

The reversible nature of protein phosphorylation dictates that any protein kinase activity must be counteracted by protein phosphatase activity. How phosphatases target specific phosphoprotein substrates and reverse the action of kinases, however, is poorly understood in a biological context. We address this question by elucidating a novel function of the conserved PP4 family phosphatase Pph3-Psy2, the yeast counterpart of the mammalian PP4c-R3 complex, in the glucose-signaling pathway. Our studies show that Pph3-Psy2 specifically targets the glucose signal transducer protein Mth1 via direct binding of the EVH1 domain of the Psy2 regulatory subunit to the polyproline motif of Mth1. This activity is required for the timely dephosphorylation of the downstream transcriptional repressor Rgt1 upon glucose withdrawal, a critical event in the repression of HXT genes, which encode glucose transporters. Pph3-Psy2 dephosphorylates Mth1, an Rgt1 associated corepressor, but does not dephosphorylate Rgt1 at sites associated with inactivation, in vitro. We show that Pph3-Psy2 phosphatase antagonizes Mth1 phosphorylation by protein kinase A (PKA), the major protein kinase activated in response to glucose, in vitro and regulates Mth1 function via putative PKA phosphorylation sites in vivo. We conclude that the Pph3-Psy2 phosphatase modulates Mth1 activity to facilitate precise regulation of HXT gene expression by glucose.

Indexed as

Adaptor Proteins, Signal TransducingCyclic AMP-Dependent Protein KinasesDNA-Binding ProteinsEnzyme ActivationGene Expression Regulation, FungalGlucoseGlucose Transport Proteins, FacilitativeImmunoblottingMutationNuclear ProteinsPhosphoprotein PhosphatasesPhosphorylationProtein BindingReverse Transcriptase Polymerase Chain ReactionSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAdaptor Proteins, Signal TransducingCyclic AMP-Dependent Protein KinasesDNA-Binding ProteinsGlucoseGlucose Transport Proteins, FacilitativeHXT1 protein, S cerevisiaeMTH1 protein, S cerevisiaeNuclear ProteinsPhosphoprotein PhosphatasesPPH3 protein, S cerevisiaePsy2 protein, S cerevisiaeRGT1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsTranscription Factors

Identifiers

PMID24277933
PMCPMC3911506
OpenAlexW1976549406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.